CADTH conducted a Health Technology Review on remdesivir, an antiviral drug currently being used to treat COVID-19. Presently, remdesivir is not approved in Canada and access to it is limited to clinical trials. Four randomized controlled trials were identified (two completed and two ongoing) in the review; however, due to insufficient published evidence, the potential place in therapy of remdesivir is unknown.

Link to Report

Remdesivir: Evidence Review and Appraisal

Provide Feedback

Was this site helpful?

If you couldn’t find what you are looking for, please submit a request.